Chargement en cours...
Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis
C3 glomerulopathy (C3G) is characterized by C3 deposits with minimal immunoglobulin deposition caused by alternative complement pathway dysregulation. Unfortunately, no therapeutic intervention has consistently improved outcomes for patients with C3G. Eculizumab, a monoclonal antibody to C5, is curr...
Enregistré dans:
| Publié dans: | Clin Kidney J |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515899/ https://ncbi.nlm.nih.gov/pubmed/26251714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv044 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|